Methodological Study to Compare the Effect of Different Methods of Measuring Cat Allergy Symptoms in Patients That Have Immunized Their Cats With FEL-CMV.
NCT ID: NCT03089788
Last Updated: 2018-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2017-03-30
2018-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Skin Tests in Cat Allergic Patients With Cat Dander Samples Obtained Before and After Vaccinating the Cat
NCT02667379
A Pilot Study for the Determination of Allergenicity of Cat Dander Samples Obtained by Different Methods
NCT02050412
Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)
NCT02163122
A Comparison of Skin Prick Tests, Clinical Symptoms, and Nasal Challenge Using a New Mouse Extract
NCT01063985
Microassay and Allergy Skin Prick Test Correlation Study
NCT03514303
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Home-based test and skin test
Home-based test
Home-based tests in which the participant pets his/her cat until he/she reaches a certain symptom strength.
Skin test
Skin Prick Tests will be performed with registered cat allergen extract.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home-based test
Home-based tests in which the participant pets his/her cat until he/she reaches a certain symptom strength.
Skin test
Skin Prick Tests will be performed with registered cat allergen extract.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 to 65 years, male or female
* Participant understands the nature, meaning and scope of the study
* Positive screening prick test (wheal diameter ≥ 3mm) to Histamine dihydrochloride 10mg/ml
* Positive screening prick test (mean wheal diameter ≥ 3 mm) when tested with already standardized cat allergen extract
* Positive screening scratch test when tested with cat dander sample of participant's cat.
* Living with a cat in the same household and parallel participation in the cat study in which the cat will be immunized
* A positive clinical history with inhalant allergy presumably due to cat allergen
Exclusion Criteria
* Other previous or current condition or participation in clinical trials influencing the results of the present study by discretion of the investigator
* Incapable of understanding the nature, meaning or scope of the research project or incapable of giving written informed consent
* Unwilling or incapable of following the study procedures, e.g. due to language problems, psychological disorders, dementia, known or suspected drug or alcohol abuse etc.
* Women who are pregnant or breast feeding or having the intention to become pregnant during the course of the study
* Positive skin reaction in the screening prick test to negative control
* History of anaphylactic reaction to pet allergens
* Severe diseases influencing the results of the present study by discretion of the investigator
* Immunotherapy with Fel d 1 / cat allergen preparation during the past two years.
* Skin lesions and excessive hair growth in the skin test areas
* Treatment with prohibited concomitant medications with the exception of medications with local effects which will not influence the results of the skin tests and the results of the other tests (testing period)
* The participant should not suffer from other respiratory allergies during this study (people who suffer from asthma are not excluded)
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Kuendig
Prof. Dr. med
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZU-HypoCat-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.